Your browser doesn't support javascript.
loading
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.
Strati, Paolo; Garcia-Manero, Guillermo; Zhao, Chong; Kadia, Tapan; Borthakur, Gautam; Konopleva, Marina; Daver, Naval; DiNardo, Courtney D; Short, Nicholas J; Yilmaz, Musa; Naqvi, Kiran; Alvarado, Yesid; Pierce, Sherry A; Cortes, Jorge; Bueso-Ramos, Carlos; Kantarjian, Hagop; Ravandi, Farhad.
Affiliation
  • Strati P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhao C; Department of Hemato-Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cortes J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bueso-Ramos C; Department of Hemato-Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Hematol ; 94(7): E188-E190, 2019 07.
Article in En | MEDLINE | ID: mdl-30977182
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Blast Crisis Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Blast Crisis Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2019 Type: Article